Federal Register / Vol. 87, No. 77 / Thursday, April 21, 2022 / Notices 23877 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Bioengineering 

Sciences & Technologies Integrated Review 

Group; Biodata Management and Analysis 

Study Section. 

Date: June 2–3, 2022. 

Time: 9:00 a.m. to 8:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: E. Bryan Crenshaw, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 480–7129, bryan.crenshaw@

nih.gov. 

Name of Committee: Risk, Prevention and 

Health Behavior Integrated Review Group; 

Psychosocial Development, Risk and 

Prevention Study Section. 

Date: June 2–3, 2022. 

Time: 9:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Anna L. Riley, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3114, 

MSC 7759, Bethesda, MD 20892, 301–435– 

2889 rileyann@csr.nih.gov. 

Name of Committee: Cell Biology 

Integrated Review Group; Biology and 

Development of the Eye Study Section. 

Date: June 2–3, 2022. 

Time: 10:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Kevin Czaplinski, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, 6701 Rockledge Drive, 

Bethesda, MD 20892, (301) 480–9139, 

czaplinskik2@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: April 15, 2022. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–08501 Filed 4–20–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Dental & 

Craniofacial Research; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: NIDCR Special Grants 

Review Committee. 

Date: June 23–24, 2022. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Dental & 

Craniofacial Research, 6701 Democracy 

Boulevard, Bethesda, MD 20892 (Virtual 

Meeting). 

Contact Person: Nisan Bhattacharyya, 

Ph.D., Scientific Review Officer, Scientific 

Review Branch, National Institute of Dental 

& Craniofacial Research, National Institutes 

of Health, 6701 Democracy Boulevard, Suite 

668, Bethesda, MD 20892, 301–451–2405, 

nisan.bhattacharyya@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program No. 93.121, Oral Diseases and 

Disorders Research, National Institutes of 

Health, HHS) 

Dated: April 18, 2022. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–08521 Filed 4–20–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Notice of Meeting 

Pursuant to Public Law 92–463, 

notice is hereby given that the 

Substance Abuse and Mental Health 

Services Administration’s (SAMHSA) 

Center for Substance Abuse Prevention’s 

(CSAP) Drug Testing Advisory Board 

(DTAB) will convene via web 

conference on June 21st, 2022, from 

10:00 a.m. EDT to 4:30 p.m. EDT, and 

June 22nd, 2022, from 10:00 a.m. EDT 

to 1:00 p.m. EDT. 

The board will meet in open-session 

June 21st, 2022, from 10:00 a.m. EDT to 

2:15 p.m. EDT to discuss the Mandatory 

Guidelines for Federal Workplace Drug 

Testing Programs, updates on the Drug 

Free Workplace Program as well as 

updates from the Department of 

Transportation, the Nuclear Regulatory 

Commission, a presentation by Dr. Barry 

Sample on Workforce Drug Testing for 

Marijuana in 2021, and a presentation 

by Dr. Svante Vikingsson on Hydroxy 

Cocaine and Cocaine Ratios in Hair. 

The board will meet in closed-session 

on June 21st, 2022, from 2:45 p.m. EDT 

to 4:30 p.m. EDT and June 22nd, 2022, 

from 10:00 a.m. EDT to 1:00 p.m. EDT, 

to discuss confidential issues 

surrounding the proposed Mandatory 

Guidelines for Federal Workplace Drug 

Testing Programs (hair), preliminary 

and unpublished studies on hydroxy 

cocaine and cocaine ratios in hair, 

studies on quantitative agreement in 

hair labs, and oral fluid topical solution 

data from the Johns Hopkins University 

Behavioral Pharmacology Research Unit 

(BPRU). Therefore, the June 21st, 2022, 

from 2:45 to 4:30 and June 22nd, 2022, 

from 10:00 a.m. EDT to 1:00 p.m. EDT 

meetings are closed to the public, as 

determined by the Assistant Secretary 

for Mental Health and Substance Use, 

SAMHSA, in accordance with 5 U.S.C. 

552b(c)(4) and (9)(B), and 5 U.S.C. App. 

2, Section 10(d). 

Meeting registration information can 

be completed at http://

snacregister.samhsa.gov/ 

MeetingList.aspx. Web conference and 

call information will be sent after 

completing registration. Meeting 

information and a roster of DTAB 

members may be obtained by accessing 

the SAMHSA Advisory Committees 

website, https://www.samhsa.gov/ 

about-us/advisory-councils/meetings or 

by contacting the Designated Federal 

Officer, Lisa Davis. 


jspears on DSK121TN23PROD with NOTICES1
23878 Federal Register / Vol. 87, No. 77 / Thursday, April 21, 2022 / Notices 

Committee Name: Substance Abuse and 

Mental Health Services 

Administration, Center for 

Substance Abuse Prevention, Drug 

Testing Advisory Board 

Dates/Time/Type: June 21st, 2022, from 

10:00 a.m. EDT to 2:15 p.m. EDT: 

OPEN, 

June 21st, 2022, from 2:45 p.m. EDT to 

4:30 p.m. EDT: CLOSED, 

June 22nd, 2022, from 10:00 a.m. EDT 

to 1:00 p.m. EDT: CLOSED 

Place: Substance Abuse and Mental 

Health Services Administration, 

5600 Fishers Lane, Rockville, MD 

20857 

Contact: Lisa S. Davis, M.S, Social 

Science Analyst, Center for 

Substance Abuse Prevention, 5600 

Fishers Lane, Rockville, Maryland 

20857, Telephone: (240) 276–1440, 

Email: Lisa.Davis@samhsa.hhs.gov. 

Anastasia Marie Donovan, 

Public Health Advisor, Division of Workplace 

Programs. 

[FR Doc. 2022–08479 Filed 4–20–22; 8:45 am] 

BILLING CODE 4162–20–P 

DEPARTMENT OF HOMELAND 

SECURITY 

[Docket Number DHS–2022–0018] 

Agency Information Collection 

Activities: REAL ID Applicant 

Information and Documentation 

AGENCY: Department of Homeland 

Security (DHS). 

ACTION: 60-Day notice and request for 

comments. 

SUMMARY: The Department of Homeland 

Security, will submit the following 

Information Collection Request (ICR) to 

the Office of Management and Budget 

(OMB) for review and clearance in 

accordance with the Paperwork 

Reduction Act of 1995. 

DATES: Comments are encouraged and 

will be accepted until June 21, 2022. 

This process is conducted in accordance 

with 5 CFR 1320.1. 

ADDRESSES: You may submit comments, 

identified by docket number Docket 

#DHS–2022–0018 at: 

Æ Federal eRulemaking Portal: http:// 

www.regulations.gov. Please follow the 

instructions for submitting comments. 

Instructions: All submissions received 

must include the agency name and 

docket number Docket #DHS–2022– 

0018. All comments received will be 

posted without change to http://

www.regulations.gov, including any 

personal information provided. 

Docket: For access to the docket to 

read background documents or 

comments received, go to http://

www.regulations.gov. 

SUPPLEMENTARY INFORMATION: The REAL 

ID Act of 2005 (the Act) prohibits 

Federal agencies from accepting Stateissued drivers’ licenses or identification 

cards for any official purpose—defined 

in the Act and regulations to include 

accessing federal facilities, boarding 

federally regulated commercial aircraft, 

and entering nuclear power plants— 

unless the license or card is issued by 

a State that meets the requirements set 

forth in the Act. The REAL ID 

regulations, which DHS issued in 

January 2008, establish the minimum 

standards that States must meet to 

comply with the Act. DHS has a 

separate collection of information 

related to DHS interaction with States, 

e.g., State certification (see OMB Control 

No. 1601–0005). By contrast to that 

collection of information, this collection 

of information relates to the States’ 

collection of information from driver’s 

license applicants. 

Initial Information and Documentation 

The Act and regulations also prescribe 

the documents and information an 

individual must present as proof of 

identity and lawful status when 

applying for a REAL ID compliant 

license or identification card. This 

includes information and 

documentation establishing a person’s 

identity, date of birth, social security 

number, residence address, and 

evidence of U.S. citizenship or lawful 

status in the United States. 

Additionally, states may permit an 

applicant to establish a name other than 

the name that appears on a source 

document but must require evidence of 

the name change through presentation 

of documents issued by a court, 

governmental body or other entity as 

determined by the state. The costs of 

these activities are one-time costs 

because they accrue as part of the initial 

issuance process only. 

Reissuance and Renewal 

With certain exceptions, the REAL ID 

regulations generally permit an 

applicant to renew or obtain a reissued 

replacement REAL ID license or 

identification card remotely and 

without presenting additional 

documentation or information. States 

may not, however, remotely renew or 

reissue a replacement license or 

identification card where there has been 

a material change in any personally 

identifiable information since the prior 

issuance. In such cases, an applicant 

must present documentation 

establishing the material change. The 

regulations also require applicants to 

renew their REAL ID licenses and 

identification cards in-person at least 

once every sixteen years. Additionally, 

holders of temporary or limited-term 

REAL ID driver’s licenses and 

identification cards must present 

evidence of continued lawful status 

when renewing their license or 

identification card. 

In addition to requiring applicants to 

present certain identity and lawful 

status documentation and information 

as described in paragraph 1 above, the 

REAL ID Act and regulations require 

states to verify and retain copies of that 

information. These requirements help 

states to ensure the authenticity of an 

applicant’s information and reduce 

opportunities for fraud in the 

application and document issuance 

process. The regulations specifically 

require states to verify identity and 

lawful status information and 

documentation presented by an 

applicant to ensure (1) the source 

document provided is genuine and has 

not been altered (‘‘document 

authentication’’), and (2) the identity 

data contained on the document is valid 

(‘‘data verification’’). States must verify 

documents and information provided by 

an applicant with the issuer of the 

document and use electronic validation 

systems as they become available for 

use. For example, to verify an 

applicant’s lawful status in the United 

States, the regulations require states to 

verify a document issued by the 

Department of Homeland Security 

through the use of the Systematic Alien 

Verification for Entitlements (SAVE) 

system or alternate method approved by 

DHS. Similarly, states must verify 

documents issued by the U.S. 

Department of State, including U.S. 

passports, with the Department of State, 

social security information with the 

Social Security Administration, and 

birth certificates using the Electronic 

Verification of Vital Events (EVVE) 

system or other electronic system when 

the records are available. The 

regulations also require state 

department of motor vehicle employees 

who are involved in the handling of an 

applicant’s source documents or who 

are engaged in the issuance of driver’s 

licenses and identification cards to 

undergo periodic fraudulent document 

recognition training and security 

awareness training. The Act and 

regulations also require states to retain 

copies of the application, declaration, 

and source documents, including 

documents establishing name changes 

for either seven years or ten years 

depending on whether the documents 


jspears on DSK121TN23PROD with NOTICES1